Dhavalkumar Dhirajlal Patel
EVP, Chief Scientific Officer · Sana Biotechnology, Inc.
Individual
- 2026
- Aug 27, 2026
- 1
Other insiders active in the same sector
No other insider has filed at Dhavalkumar Dhirajlal Patel's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Stephen M. Bloch - $125.05M in LQDA purchases and sales in the last 12 months
- Jason P. Rhodes - $124.92M in DYN purchases and sales in the last 12 months
- Matthew Rabinowitz - $124.05M in NTRA purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $118.63M in KOD purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $117.62M in ARTV purchases and sales in the last 12 months
- SVF Pauling (Cayman) Ltd - $116.40M in RLAY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Dhavalkumar Dhirajlal Patel?
Dhavalkumar Dhirajlal Patel is a corporate insider, tracked as EVP, Chief Scientific Officer of Sana Biotechnology, Inc. (SANA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Dhavalkumar Dhirajlal Patel submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
